DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — Chimerix Inc. (CMRX) on Thursday reported a loss of $21 million in its fourth quarter.
The Durham, North Carolina-based company said it had a loss of 24 cents per share.
The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 24 cents per share.
The biopharmaceutical company posted revenue of $814,000 in the period.
For the year, the company reported net income of $172.2 million, or $1.94 per share, swinging to a profit in the period. Revenue was reported as $33.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CMRX">Zacks stock report on CMRX at https://www.zacks.com/ap/CMRX